Successful treatment of avian-origin influenza A (H7N9) infection using convalescent plasma

Highlights • The mortality rate for avian-origin influenza A (H7N9) infections remains high (52%). • We successfully used convalescent plasma to treat an H7N9 infection in a 45-year-old man. • We are the first to use oseltamivir and convalescent plasma to treat H7N9 in China.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	International journal of infectious diseases 2015-12, Vol.41 (C), p.3-5
Hauptverfasser:	Wu, Xiao-Xin, Gao, Hai-Nv, Wu, Hai-Bo, Peng, Xiu-Ming, Ou, Hui-Lin, Li, Lan-Juan
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral Agents - therapeutic use Blood Component Transfusion China - epidemiology Convalescent plasma Disease Outbreaks H7N9 Humans Infectious Disease Influenza A Virus, H7N9 Subtype - isolation & purification Influenza, Human - therapy Influenza, Human - virology Male Middle Aged Oseltamivir Oseltamivir - therapeutic use Plasma Pulmonary/Respiratory
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Highlights • The mortality rate for avian-origin influenza A (H7N9) infections remains high (52%). • We successfully used convalescent plasma to treat an H7N9 infection in a 45-year-old man. • We are the first to use oseltamivir and convalescent plasma to treat H7N9 in China.
ISSN:	1201-9712 1878-3511
DOI:	10.1016/j.ijid.2015.10.009